Delaware
|
001-36003
|
20-3183915
|
||
(State or Other Jurisdiction
of Incorporation)
|
(Commission
File Number)
|
(IRS Employer
Identification No.)
|
16745 West Bernardo Dr., Suite 200
San Diego, CA
|
92127
|
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 5.02 |
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
|
Date: March 5, 2015 |
CONATUS PHARMACEUTICALS INC.
|
||||
By: |
/s/ Charles J. Cashion
|
||||
Name: | Charles J. Cashion | ||||
Title: |
Senior Vice President, Finance,
|
||||
Chief Financial Officer and Secretary
|